Free Trial

SurgePays (NASDAQ:SURG) Shares Cross Above Two Hundred Day Moving Average - Should You Sell?

SurgePays logo with Computer and Technology background

Key Points

  • SurgePays' stock price has recently surpassed its 200-day moving average, reaching as high as $2.83 before closing at $2.76 on a trading volume of 37,351 shares.
  • Analysts have upgraded SurgePays from a "sell" to a "hold" rating, with a consensus price target of $9.00, indicating positive sentiment toward the stock.
  • Despite a revenue miss in its latest quarterly earnings, with actual revenue of $11.52 million compared to expectations of $16.14 million, SurgePays is still forecasted to improve earnings per share in the current fiscal year.
  • Five stocks we like better than SurgePays.

SurgePays, Inc. (NASDAQ:SURG - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $2.53 and traded as high as $2.83. SurgePays shares last traded at $2.76, with a volume of 37,351 shares changing hands.

Wall Street Analysts Forecast Growth

Several research firms recently commented on SURG. Wall Street Zen upgraded SurgePays from a "sell" rating to a "hold" rating in a research report on Saturday, August 30th. Ascendiant Capital Markets boosted their price objective on shares of SurgePays from $8.75 to $9.00 and gave the stock a "buy" rating in a research note on Monday, June 16th. One research analyst has rated the stock with a Buy rating, According to MarketBeat, the company has an average rating of "Buy" and an average price target of $9.00.

Get Our Latest Stock Analysis on SURG

SurgePays Stock Performance

The company has a current ratio of 1.11, a quick ratio of 0.84 and a debt-to-equity ratio of 101.87. The firm's 50-day moving average is $2.79 and its two-hundred day moving average is $2.56. The stock has a market cap of $60.68 million, a price-to-earnings ratio of -1.19 and a beta of 0.43.

SurgePays (NASDAQ:SURG - Get Free Report) last released its quarterly earnings results on Wednesday, August 13th. The medical equipment provider reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.31) by ($0.05). SurgePays had a negative return on equity of 333.87% and a negative net margin of 133.85%.The company had revenue of $11.52 million for the quarter, compared to analyst estimates of $16.14 million. SurgePays has set its FY 2025 guidance at EPS. As a group, sell-side analysts expect that SurgePays, Inc. will post -1.66 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. D.A. Davidson & CO. purchased a new position in SurgePays in the 1st quarter worth approximately $25,000. Goldman Sachs Group Inc. purchased a new position in SurgePays in the 1st quarter worth approximately $28,000. Baader Bank Aktiengesellschaft purchased a new position in SurgePays in the 1st quarter worth approximately $35,000. Jane Street Group LLC purchased a new position in SurgePays in the 2nd quarter worth approximately $42,000. Finally, Ethos Financial Group LLC purchased a new position in SurgePays in the 1st quarter worth approximately $57,000. Institutional investors and hedge funds own 6.94% of the company's stock.

About SurgePays

(Get Free Report)

SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.

See Also

Should You Invest $1,000 in SurgePays Right Now?

Before you consider SurgePays, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SurgePays wasn't on the list.

While SurgePays currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.